C-peptide vs Desmopressin
Head-to-head comparison of C-peptide (Connecting peptide (C-peptide)) and Desmopressin (1-Deamino-8-D-arginine vasopressin) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | C-peptide | Desmopressin |
|---|---|---|
| Category | Pain Management | Cognitive Enhancement |
| Full Name | Connecting peptide (C-peptide) | 1-Deamino-8-D-arginine vasopressin |
| Molecular Weight | 3020.3 Da | 1069.22 Da |
| Half-Life | ~20-30 min | 1.5-3 hours |
| Amino Acids | 31 | 9 |
| Typical Dose | no approved analgesic dose|research-only | 10-40 mcg intranasal |
| Route | IV|subQ | Intranasal/Oral |
| Purity | ≥98% | ≥98% |
| Studies Count | 46 | 35 |
| Research Status | Pre-clinical | Clinical |
C-peptide Benefits
- ✓diabetic neuropathy research
- ✓nerve function support
- ✓possible analgesic effect
Desmopressin Benefits
- ✓memory consolidation
- ✓reduced pressor burden
- ✓recall support
- ✓short-term learning
C-peptide Dosing
0.5-1.0 mg/day in research|route varies by protocol
Desmopressin Dosing
intranasal research dosing|10-40 mcg or IU-equivalent studies|single-dose protocols
C-peptide Side Effects
- ⚠injection-site reactions
- ⚠unknown long-term safety
Desmopressin Side Effects
- ⚠hyponatremia
- ⚠headache
- ⚠nasal irritation
Research Overview
C-peptide
C-peptide is not an approved analgesic, but multiple studies have examined its effects on peripheral nerve blood flow and neuropathy outcomes. The strongest relevance is in diabetic neuropathic pain rather than migraine.
Desmopressin
The literature is mixed, but desmopressin has shown memory-related effects in selected populations and experimental paradigms. Its cognitive effects are usually discussed as a vasopressin-pathway probe rather than a primary nootropic.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.